Creating a quick test to detect Treponema pallidum infections.
Official title: SBIR Topic 108: Development of Rapid Molecular Assay for Point of Care Detection of Treponema Pallidum
Funded at Tetracore, INC. · NIH-11203269 · Data updated 2026-11-12
This study is working on a quick and easy test that doctors can use right away to check for syphilis, helping patients get the right treatment faster and reducing the chance of spreading the infection.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tetracore, INC. NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project start | September 3, 2024 |
| Project end | September 2, 2027 |
| Funding year | 2024 |
| Award (this year) | $1,488,107 |
| NIH project number | 75N93024C00073-0-9999-1 |
| Project ID | NIH-11203269 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who are at risk for syphilis or have symptoms suggestive of a Treponema pallidum infection.
✕Less likely to help
Patients who are not at risk for syphilis or have already been diagnosed and treated for the infection may not benefit from this research.
What this research studies
This research focuses on developing a rapid molecular assay that can be used at the point of care to detect Treponema pallidum, the bacterium responsible for syphilis. The approach aims to provide healthcare providers with a fast and accurate diagnostic tool, which can lead to timely treatment for patients. By utilizing advanced molecular techniques, the assay is designed to deliver results quickly, potentially improving patient outcomes and reducing the spread of infection. The research will involve testing the assay's effectiveness in real-world settings to ensure its reliability and usability.
Why it matters
Potential benefit: If successful, this research could enable faster diagnosis and treatment of syphilis, improving health outcomes for patients.
How similar studies have gone: Similar research efforts in developing rapid diagnostic tests for infectious diseases have shown promise, indicating that this approach could be effective.
Where this research is happening
-
Tetracore, INC.
Rockville, United States Active
Researchers
- Principal investigator: Cockrell, Lisa — Tetracore, INC.
- Study coordinator: Cockrell, Lisa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.